文献速递肝病消化道肿瘤与早癌

术前钆塞酸增强MRI预测单发肝细胞癌微血管侵犯

Preoperative gadoxetic acid-enhanced MRI for predicting microvascular invasion in patients with single hepatocellular carcinoma.
PubMed 文献 · J Hepatol · 2017-05-06

本研究纳入197例接受手术切除的单发肝细胞癌(≤5cm)患者,术前均行钆塞酸增强MRI。动脉期瘤周强化、肿瘤边缘不光滑、肝胆期瘤周低信号是预测微血管侵犯的独立影像学特征,三项中满足两项时特异度92.5%(124/134),满足三项时特异度99.3%(133/134)。具有两项或三项上述特征的患者术后早期复发率显著高于无上述特征者(27.9% vs 12.6%,p=0.030)。

要点

  • 动脉期瘤周强化、肿瘤边缘不光滑、肝胆期瘤周低信号是预测微血管侵犯的独立MRI特征。
  • 三项特征中满足两项时特异度92.5%(124/134),满足三项时特异度99.3%(133/134)。
  • 具有两项或三项特征者术后早期复发率显著高于无上述特征者(27.9% vs 12.6%,p=0.030)。

核心结论

  • 三项MRI特征中满足两项或以上可作为术前预测微血管侵犯的影像学生物标志物,特异度>90%,且与单发肝细胞癌术后早期复发相关。

研究设计与样本

  • 研究纳入197例接受手术切除的单发肝细胞癌(≤5cm)患者,术前均行钆塞酸增强MRI。
  • 采用单因素和多因素分析筛选预测微血管侵犯的显著MRI表现,并分析早期复发率(<2年)与这些影像学特征的关系。

主要发现

  • 动脉期瘤周强化与微血管侵犯独立相关(OR=5.184;95%CI:2.228,12.063;p<0.001)。
  • 肿瘤边缘不光滑与微血管侵犯独立相关(OR=3.555;95%CI:1.627,7.769;p=0.001)。
  • 肝胆期瘤周低信号与微血管侵犯独立相关(OR=4.705;95%CI:1.671,13.246;p=0.003)。
  • 三项特征中满足两项时特异度为92.5%(124/134),满足三项时特异度为99.3%(133/134)。
  • 具有两项或三项显著MRI特征的单发肝细胞癌患者早期复发率显著高于无上述特征者(27.9% vs 12.6%,p=0.030)。

关键数值与推荐

  • 动脉期瘤周强化预测微血管侵犯的OR=5.184(95%CI:2.228,12.063;p<0.001)。
  • 肿瘤边缘不光滑预测微血管侵犯的OR=3.555(95%CI:1.627,7.769;p=0.001)。
  • 肝胆期瘤周低信号预测微血管侵犯的OR=4.705(95%CI:1.671,13.246;p=0.003)。
  • 三项特征中满足两项时特异度92.5%(124/134),满足三项时特异度99.3%(133/134)。

临床怎么用

  • 作者认为,三项MRI特征中满足两项或以上可作为术前预测微血管侵犯的影像学生物标志物,特异度>90%,并与单发肝细胞癌术后早期复发相关。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: This study aimed to identify preoperative magnetic resonance (MR) imaging biomarkers for predicting microvascular invasion (MVI), to determine their diagnostic performance and to evaluate whether they are associated with early recurrence after surgery for single hepatocellular carcinoma (HCC). METHODS: The study included 197 patients with surgically resected HCC (≤5cm) who underwent preoperative gadoxetic acid-enhanced MR imaging. Significant MR imaging findings for predicting MVI were identified by univariate and multivariate analyses. Early recurrence rates (<2years) were analyzed with respect to significant imaging findings for predicting MVI. RESULTS: Three MR imaging features were independently associated with MVI: arterial peritumoral enhancement (odds ratio [OR]=5.184; 95% confidence interval [CI]: 2.228, 12.063; p<0.001), non-smooth tumor margin (OR=3.555; 95% CI: 1.627, 7.769; p=0.001), and peritumoral hypointensity on hepatobiliary phase (HBP) (OR=4.705; 95% CI: 1.671, 13.246; p=0.003). When two of three findings were combined, the specificity was 92.5% (124/134). When all three findings were satisfied, the specificity was 99.3% (133/134). Early recurrence rates were significantly higher in patients with single HCC, with two or three significant MR imaging findings, compared to those with none (27.9% vs. 12.6%, respectively, p=0.030). CONCLUSIONS: A combination of two or more of the following; arterial peritumoral enhancement, non-smooth tumor margin, and peritumoral hypointensity on HBP, can be used as a preoperative imaging biomarker for predicting MVI, with specificity >90%, and is associated with early recurrence after surgery of single HCC. Lay summary: A combination of two or more of the following; arterial peritumoral enhancement, non-smooth tumor margin, and peritumoral hypointensity on hepatobiliary phase, can be used as a preoperative imaging biomarker for predicting microvascular invasion, with specificity >90%, and is associated with early recurrence after curative resection of single HCC.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Lee S, Kim SH, Lee JE, et al. Preoperative gadoxetic acid-enhanced MRI for predicting microvascular invasion in patients with single hepatocellular carcinoma. J Hepatol. 2017. PMID: 28483680. doi:10.1016/j.jhep.2017.04.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。